Charges against Valeant's secret pharmacy could be imminent
It's not clear yet, exactly what the charges will entail. The DOJ's investigation into Philidor's sales tactics has been said to include the company's CEO, Andy Davenport as well as another executive Gary Tanner.
Tanner led Valeant's Access Team before moving to Philidor to help build a national network of pharmacy partners.
The probe is focused on Valeant's $100 million acquisition of an option to buy Philidor, according to the people.
US prosecutors are separately investigating former Valeant CEO Michael Pearson and CFO Howard Schiller, Bloomberg News has reported.
Philidor is at the heart of the scandal that erased 90% of Valeant Pharmaceutical's market value. Almost no one had heard of the pharmacy until Valeant's relationship with Philidor was exposed by the Southern Investigative Reporting Foundation in October of 2015.
After questions about Philidor's sales tactics arose, investors abandoned the former Wall Street darling in droves.
Valeant had a sales plan dubbed the "Philidor strategy" and company documents show that it used the pharmacy and increase the volume of shipments for two of its drugs, Solodyn and Jublia.
- Indian markets could recover on Monday but earnings, global cues will decide the rest of the week, say experts
- Top temples to visit in India you must visit atleast once in a lifetime
- Top 10 adventure sports across India: Where to experience them in 2024
- Market recap: Valuation of 6 of top 10 firms declines by Rs 68,417 cr; Airtel biggest laggard
- West Bengal Elections: Rift among INDIA bloc partners triggers three-cornered intense contests
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market